NPI Details
James Scruggs, MD is an internal medicine in Wheaton, IL with 43 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. James Scruggs, MD NPI is 1407824089. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Graduation Year:1983
The provider's business location address is:
150 E WILLOW AVE STE 200
WHEATON, IL
ZIP 60187-529
Phone: (630) 665-6200
The NPI 1407824089 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Blood test, clotting time (HCPCS:85610)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Hemoglobin a1c level (HCPCS:83036)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
- Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
- Uric acid level, blood (HCPCS:84550)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Urine microalbumin (protein) level (HCPCS:82043)
- Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
- Iron level (HCPCS:83540)
- Iron binding capacity (HCPCS:83550)
- Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
- Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
- Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
- Amylase (enzyme) level (HCPCS:82150)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
The enumeration date for this NPI number is 3/9/2006 and was last updated on 2/26/2021.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207RG0300X | Internal Medicine | Geriatric Medicine | 036069251 | ILLINOIS | No |
| 2 | 207R00000X | Internal Medicine | | 036069251 | ILLINOIS | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 036069251 | MEDICAID | ILLINOIS | |
